Literature DB >> 18977853

Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.

Masamichi Nagae1, Nozomu Nishi, Takeomi Murata, Taichi Usui, Takanori Nakamura, Soichi Wakatsuki, Ryuichi Kato.   

Abstract

Galectins are a family of beta-galactoside-specific lectins bearing a conserved carbohydrate recognition domain. Interactions between galectins and poly-N-acetyllactosamine sequences are critical in a variety of biological processes. Galectin-9, a member of the galectin family, has two carbohydrate recognition domains at both the N- and C-terminal regions. Here we report the crystal structure of the human galectin-9 N-terminal carbohydrate recognition domain in complex with N-acetyllactosamine dimers and trimers. These complex structures revealed that the galectin-9 N-terminal carbohydrate recognition domain can recognize internal N-acetyllactosamine units within poly-N-acetyllactosamine chains. Based on these complex structures, we propose two putative recognition modes for poly-N-acetyllactosamine binding by galectins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977853     DOI: 10.1093/glycob/cwn121

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  23 in total

Review 1.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Diversity in recognition of glycans by F-type lectins and galectins: molecular, structural, and biophysical aspects.

Authors:  Gerardo R Vasta; Hafiz Ahmed; Mario A Bianchet; José A Fernández-Robledo; L Mario Amzel
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 3.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

4.  Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains.

Authors:  Pablo Guardado-Calvo; Eva M Muñoz; Antonio L Llamas-Saiz; Gavin C Fox; Richard Kahn; David T Curiel; Joel N Glasgow; Mark J van Raaij
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose.

Authors:  Hiromi Yoshida; Misa Teraoka; Nozomu Nishi; Shin-ichi Nakakita; Takanori Nakamura; Mitsuomi Hirashima; Shigehiro Kamitori
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

Review 6.  When galectins recognize glycans: from biochemistry to physiology and back again.

Authors:  Santiago Di Lella; Victoria Sundblad; Juan P Cerliani; Carlos M Guardia; Dario A Estrin; Gerardo R Vasta; Gabriel A Rabinovich
Journal:  Biochemistry       Date:  2011-08-26       Impact factor: 3.162

7.  Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans.

Authors:  Wenjie Peng; Jennifer Pranskevich; Corwin Nycholat; Michel Gilbert; Warren Wakarchuk; James C Paulson; Nahid Razi
Journal:  Glycobiology       Date:  2012-07-11       Impact factor: 4.313

8.  Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Authors:  Albert Lee; Joel M Chick; Daniel Kolarich; Paul A Haynes; Graham R Robertson; Maria Tsoli; Lucy Jankova; Stephen J Clarke; Nicolle H Packer; Mark S Baker
Journal:  Mol Cell Proteomics       Date:  2010-02-18       Impact factor: 5.911

9.  NMR and MD investigations of human galectin-1/oligosaccharide complexes.

Authors:  Christophe Meynier; Mikael Feracci; Marion Espeli; Florence Chaspoul; Philippe Gallice; Claudine Schiff; Françoise Guerlesquin; Philippe Roche
Journal:  Biophys J       Date:  2009-12-16       Impact factor: 4.033

10.  TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections.

Authors:  Roger Tieu; Praveen Kumar Amancha; François Villinger; Siddappa N Byrareddy
Journal:  Austin Virol Retro Virol       Date:  2014-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.